Pradaxa 150 mg, Kapseln

7680613850181 CH-61385 Kapseln

Associated product:

PRADAXA caps 150 mg 60 pce
Pradaxa 150 mg, Kapseln
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
60
Selling units
60
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/02/2024
Patient information leaflet
Français
26/02/2024
Patient information leaflet
Italien
26/02/2024
Summary of Product Characteristics
Allemand
26/02/2024
Summary of Product Characteristics
Français
26/02/2024
Summary of Product Characteristics
Italien
26/02/2024

Detailed composition

Substance Quantity Type Category
dabigatranum etexilatum
150.0 MG Substance Wirkstoff (Principe actif)
dabigatrani etexilati mesilas
172.95 MG Substance WIZUS
acaciae gummi
- Substance HNIDK
acidum tartaricum
- Substance HNIDK
hypromellosum
- Substance HNIDK
dimeticonum
- Substance HNIDK
talcum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
carrageenanum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
E 171
- Substance FNIDK
E 132
- Substance FIMDK
aqua purificata
- Substance HNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
kalii hydroxidum
- Substance HNIDK

Reimbursement information

Public price
CHF 65.15
Specialties list
Yes
Generic
No
SL addition date: 01/07/2012

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
61385
Drug name
Pradaxa, Kapseln
Galenic form
KAPS
ATC Code
B01AE07
Authorization status
Z
Dispensing category
B
First authorization
29/05/2012
Authorization expiration date
31/12/9999
IT Number
06.03.0.
Domain
Human medicine
Field of application
Prävention von Schlaganfall und systemischer Embolie bei erwachsenen Patienten mit nicht-valvulärem Vorhofflimmern. Behandlung tiefer Venenthrombosen und/oder Lungenembolien. Prävention der rezidivierenden tiefen Venenthrombose und/oder Lungenembolie.

Package details

Description (FR)
PRADAXA caps 150 mg 60 pce
Description (DE)
PRADAXA Kaps 150 mg 60 Stk
Market launch
29/05/2012
Narcotic (BTM)
No

Available generics (8)

Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580015
CHF 60.95
View
Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580022
CHF 150.10
View
Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580039
CHF 60.95
View
Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580046
CHF 150.10
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550011
CHF 60.95
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550028
CHF 150.10
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550035
CHF 60.95
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550042
CHF 150.10
View

Other package sizes (10)

PRADAXA 75 mg caps
None None
GTIN: 7680613850013
Not in V1
PRADAXA 75 mg caps
None None
GTIN: 7680613850020
Not in V1
PRADAXA 75 mg caps
None None
GTIN: 7680613850037
Not in V1
PRADAXA 75 mg caps
None None
GTIN: 7680613850044
Not in V1
PRADAXA 110 mg caps
None None
GTIN: 7680613850068
Not in V1
PRADAXA 110 mg caps
None None
GTIN: 7680613850075
Not in V1
PRADAXA 110 mg caps
None None
GTIN: 7680613850105
Not in V1
PRADAXA 110 mg caps
None None
GTIN: 7680613850143
Not in V1
PRADAXA caps 110 mg 60 pce
60 KAP
GTIN: 7680613850150
View
PRADAXA caps 110 mg 3 x 60 pce
3 x 60 KAP
GTIN: 7680613850167
View
Buy us a coffee Explore the data